Midday movers: Apple, Eli Lilly rise; Coinbase falls

NVIDIA (NVDA) PT Raised to $150 at Citi

Citi analyst Atif Malik raised the price target on NVIDIA (NASDAQ: NVDA) to $150.00 (from $126.00) while maintaining a Buy rating.

The analyst comments "We increase our above consensus CY25/26 EPS by 7%/13% to reflect growing 2025 build plan of GB200 for both NVL36/76 configurations... More

RXO, Inc. (RXO) PT Raised to $26 at Stifel

Stifel analyst J. Bruce Chen raised the price target on RXO, Inc. (NYSE: RXO) to $26.00 (from $19.00) while maintaining a Hold rating.

The analyst comments "On Sunday, RXO agreed to acquire UPS' (UPS, $134.66, Buy) Coyote Logistics Unit for about $1bn. We think it's an... More

Apple (AAPL) PT Raised to $250 at Evercore ISI

Evercore ISI analyst Amit Daryanani raised the price target on Apple (NASDAQ: AAPL) to $250.00 (from $220.00) while maintaining a Outperform rating.

The analyst comments "Apple stock has seen a nice increase since WWDC, but we still think there is more room to run as we see potential for material upside to current iPhone revenue... More

Oppenheimer Downgrades ResMed (RMD) to Perform

Oppenheimer analyst Suraj Kalia downgraded ResMed (NYSE: RMD) from Outperform to Perform.

The analyst comments "SURMOUNT-OSA dataset was presented at ADA (NEJM link) on 06/21. While we have discussed GLP-1s/SURMOUNT-OSA at length and the risk we believe they represent to the... More

Eli Lilly (LLY) PT Raised to $1,000 at Truist Securities

Truist Securities analyst Robyn Karnauskas raised the price target on Eli Lilly (NYSE: LLY) to $1,000.00 (from $892.00) while maintaining a Buy rating.

The analyst comments "We are adjusting our model estimates ahead of the quarter to reflect script growth and management commentary on the quarter.... More

RXO, Inc. (RXO) PT Raised to $30 at Jefferies

Jefferies analyst Stephanie Moore raised the price target on RXO, Inc. (NYSE: RXO) to $30.00 (from $25.00) while maintaining a Buy rating.

The analyst comments "This is a follow-up to our note published yesterday. Recall that we are positive on the deal on the... More

Jefferies sees upside in Nvidia, raises target

Jefferies analysts are bullish on Buy-rated NVIDIA (NASDAQ: NVDA), raising their price target to $150 per share from $135 in a note Monday.

This increase reflects positive takeaways from their recent Asia trip and upcoming meetings with key players in the AI space.

In a recent note, Jefferies acknowledges mixed performance within the AI sector. While Nvidia... More

Alnylam Pharmaceuticals (ALNY) PT Raised to $250 at Morgan Stanley

Morgan Stanley analyst Andrew Galler raised the price target on Alnylam Pharmaceuticals (NASDAQ: ALNY) to $250.00 (from $164.00) while maintaining a Equalweight rating.

The analyst comments "Top-line HELIOS-B results better-than-expected, supporting sNDA filing in late 2024. We expect focus to now shift to presentation of... More

Apple (AAPL) is JPMorgan's best pick in Edge AI

JPMorgan analysts see Apple (NASDAQ: AAPL) as well-positioned in the Edge AI hardware market, highlighting its large iPhone user base and potential for higher profits compared to competitors.

In its note, the investment bank emphasizes a shift towards "Profit TAM [Total Addressable... More